"When I resigned, I gave myself six months. Not to look for another job. To understand. I wanted to know if there was, somewhere, a stable form of vitamin C. One that doesn't oxidize on contact with air. One that reaches the skin intact. And one that doesn't sting menopausal skin."
Sophie pauses, as if to measure the importance of what comes next.
"I spent whole days reading. Scientific publications, patents, reports from dermatology conferences. And after three months, I found it. It exists. It has existed for a long time. And it's called Ethyl Ascorbic Acid."
She continues softly.
"Specifically, it's a derived form of vitamin C. Chemists took the classic molecule and added a small group to it, called an ethyl group. This group acts as a shield. The active ingredient remains stable on contact with air. Stable on contact with skin. And only degrades once it has penetrated the dermis. Only then does the shield withdraw, and the vitamin C is released, intact, exactly where it needs to work. On your collagen. On your complexion. On that radiance you've lost over the last ten years."
Sophie falls silent.
"Concretely, that means three things. One: it doesn't sting. Two: it doesn't cause redness. Three: the bottle doesn't yellow, it remains clear to the last drop. You pay for active vitamin C, and you apply active vitamin C. It's that simple."
So why is no one talking about it?
"That's the question I asked myself for three weeks. Why, if this form exists, if it's better, if it's gentler, don't major brands use it? Why do they continue to put pure ascorbic acid in 50-euro bottles, knowing that it will oxidize even before the bottle is finished?"
She smiles for the first time in the interview, but it's a bitter smile.
"The answer is simple. Ethyl Ascorbic Acid costs between 7 and 10 times more to produce. When you manufacture 200,000 bottles a month for a brand that has to feed shareholders, you can't afford it. So you continue with pure ascorbic acid. You put more marketing in to compensate. And you sell products to 60-year-old women that weren't designed for them, because it's profitable."
Sophie leans slightly forward.
"And that, I couldn't do anymore. That's why I looked for the opposite. A small laboratory that would have dared to use this form. One that wouldn't manufacture 200,000 bottles a month. One that wouldn't have shareholders to feed. One that would formulate for the skin, not for the margin."
I found one. Only one.